Keep a malfunctioning Wegovy pen and packaging while seeking product support
For a Wegovy pen problem, retain the device and packaging and contact the appropriate support team. Do not discard the evidence or assume the next purchase will be reimbursed.
What this comes down to
- Preserve the device and box for the manufacturer’s evaluation.
- A product complaint and a dose decision are separate questions.
- A replacement is evaluated, not promised universally.
Use the support route for the presentation you received
The Wegovy single-dose pen instructions direct patients to a healthcare provider or Novo Nordisk if the yellow indicator fails to start or stops during injection. The manufacturer’s pen guide says to keep the pen and all packaging until speaking with Customer Care; unavailable pens may limit replacement assistance.[1][2] Keep the pen presentation and dose count with the complaint record so the device and package being reported are identified correctly.
Confirm the exact device on the carton before using a troubleshooting page. Wegovy has more than one labeled presentation, and an instruction for one device should not be silently applied to another. Use the instructions supplied with your medicine and ask the pharmacist if the presentation is unclear.
Separate treatment advice from the product claim
Tell the clinician or pharmacist what happened and whether a full dose may have been delivered. Do not independently inject another pen to compensate. Ask the product-support team what information it needs, whether to retain or return the device, and how to store it safely while the complaint is reviewed.
For the purchasing record, retain the pharmacy receipt, prescription label, carton identifiers and a dated description of the issue. These are practical recordkeeping suggestions, not a universal manufacturer claim checklist. Keep photographs without exposing account details publicly.
Ask what replacement approval actually covers
If support offers a remedy, ask whether it is a replacement product, pharmacy authorization or another arrangement, and whether any charge remains. Confirm the process before purchasing another box on the assumption that it will be reimbursed.
FDA’s MedWatch accepts product-quality and use-error reports. That reporting route is separate from the manufacturer’s remedy review and the clinician’s treatment advice. Save a support reference number so later communications can be linked to the original complaint.[3]
FDA’s reporting instructions include product identifiers and event details. A product complaint should distinguish what happened from the identifying information on the carton; the reporting form does not decide a replacement entitlement.[4]
For the related buying question, read medication storage questions.
Questions people actually ask
Is a free replacement guaranteed?
No. The manufacturer describes evaluation and warns that discarding the device can limit replacement assistance.
Should I repeat a possibly incomplete dose?
Ask the healthcare professional who manages the prescription. A purchasing guide cannot decide whether to administer another dose.
Sources
Primary sources and the claims they support.
- 1.Wegovy prescribing information and instructions. Novo Nordisk, 2026. SourceSingle-dose pen problems are directed to the healthcare provider or manufacturer.
- 2.
- 3.FDA MedWatch. FDA, 2025. Source · Document dated September 2025Product-quality and use-error reports.
- 4.FDA reporting instructions. FDA, 2026. Source · Document dated May 2026Reporting fields identify the suspect product and relevant event information.